Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response (2023)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1007/s00277-023-05189-3
- Subjects: DOENÇA CRÔNICA; LEUCEMIA MIELOIDE; SOBREVIDA; ESTUDOS MULTICÊNTRICOS; ESTUDOS RANDOMIZADOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Annals of hematology
- ISSN: 0939-5555
- Volume/Número/Paginação/Ano: v. 102, n. 7, p. 1761-1771, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
FERREIRA, Amanda Pifano Soares et al. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response. Annals of hematology, v. 102, n. 7, p. 1761-1771, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54584. Acesso em: 10 jun. 2024. -
APA
Ferreira, A. P. S., Seguro, F. S., Abdo, A. R. N., Santos, F. M., Maciel, F. V. R., Nardinelli, L., et al. (2023). Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response. Annals of hematology, 102( 7), 1761-1771. doi:10.1007/s00277-023-05189-3 -
NLM
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Rego EM, Rocha VG. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response [Internet]. Annals of hematology. 2023 ; 102( 7): 1761-1771.[citado 2024 jun. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54584 -
Vancouver
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Rego EM, Rocha VG. Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response [Internet]. Annals of hematology. 2023 ; 102( 7): 1761-1771.[citado 2024 jun. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54584 - Outcomes and second neoplasms in hairy cell leukemia: a retrospective cohort
- Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study
- Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting
- Toxicity profile of PEG-asparaginase in adult patients with acute lymphoblastic leukemia in Brazil: a multicenter cross-sectional study
- Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem
- Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation
- Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis
- Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
- Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
- Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population
Informações sobre o DOI: 10.1007/s00277-023-05189-3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
